Femring (Allergan, Inc.)


Welcome to the PulseAid listing for the Femring drug offered from Allergan, Inc.. This Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Allergan, Inc.
NON-PROPRIETARY NAME: estradiol acetate
SUBSTANCE NAME: ESTRADIOL ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA]
ROUTE: VAGINAL
DOSAGE FORM: RING
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-05-02
END MARKETING DATE: 0000-00-00


Femring HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFemring from Allergan, Inc.
LABELER NAME: Allergan, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.05(mg/d)
START MARKETING DATE: 2016-05-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0023-5868_3daf6e91-1830-49c7-b50e-1a7e856d968a
PRODUCT NDC: 0023-5868
APPLICATION NUMBER: NDA021367

Other ESTRADIOL ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan, Inc.Femring
Physicians Total Care, Inc.Femring
Warner Chilcott (US), LLCFemring